IgMN is considered to fall in the spectrum between MCD and FSGS, but it is evident that there is a distinct group of patients, identifiable by immunohistochemistry, who exhibit predominant mesangial IgM deposition and do not meet the established diagnostic criteria for either MCD or FSGS [2]. The gene discussed is CD40LG; the disease is focal segmental glomerulosclerosis.